Overview
Invitae
?
Medical and Diagnostic Laboratories
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Testing laboratories
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Modelled
?
Actual
$516.30 million
Actual
12.13%
$1,954
DEC
?
?
OTC:NVTAQ
Contacts
Get in Touch with 6 Principals* and 563 Contacts
-
Kenneth D KnightChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2022 (12 month period) in USD
Annual Revenue 2022
$516.30 million
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net Operating Cash | -$493 | -$560 | -$299 |
| Net Investing Cash | -$175 | -$204 | -$401 |
| Net Financing Cash | $2 | $1,566 | $673 |
| Net Change in Cash | -$666 | $802 | -$26 |
| Cash at Beginning of Period | $934 | $131 | $158 |
| Cash at End of Period | $268 | $934 | $131 |
| Capital Expenditure | -$53 | -$55 | -$23 |
| Assets (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $257 | $923 | $125 |
| Accounts Receivable | $96 | $66 | $48 |
| Inventories | $30 | $34 | $32 |
| Other Current Assets | $309 | $156 | $249 |
| Asset Summary | |||
| Total Current Assets | $693 | $1,179 | $454 |
| Tangible Fixed Assets | $215 | $236 | $111 |
| Intangible Assets | $1,013 | $1,188 | $982 |
| Total Assets | $1,954 | $4,920 | $3,430 |
| Liabilities (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $14 | $21 | $25 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $94 | $123 | $97 |
| Liability Summary | |||
| Total Current Liabilities | $108 | $144 | $122 |
| Long-Term Debt | $1,593 | $1,578 | $388 |
| Other Long-Term Liabilities | $4 | $9 | $14 |
| Total Liabilities | $1,852 | $1,941 | $1,454 |
| Stakeholder's Equity (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$4,829 | -$1,723 | -$1,361 |
| Equity Summary | |||
| Total Equity | $102 | $2,978 | $1,976 |
| Shares Outstanding | 245,562,121 | 228,115,734 | 185,885,658 |